Loading
companiesCompany
Amneal Pharmaceuticals
Amneal is a US generic and speciality drug maker with a growing sterile injectables business, one of the companies that stepped in as platinum chemotherapy ran short in 2023.
Overview
Amneal Pharmaceuticals, based in Bridgewater, New Jersey, makes oral and injectable generics at plants in the United States and India and has invested in sterile injectable capacity for hospital drugs, including oncology generics. It is one of the manufacturers the FDA worked with to expand supply during the 2023 cisplatin and carboplatin shortage.
Similar pages
- CompanyHikma Pharmaceuticals
Shares Generic oncology drug supply and shortage mitigation, Generic sterile injectables (the 2023 platinum shortage) and the tag manufacturing-wave.
- TechnologyGMP, inspections, Form 483s and warning letters
Shares Generic oncology drug supply and shortage mitigation, Oral solid dose manufacturing (tablets and capsules), Generic sterile injectables (the 2023 platinum shortage) and the tag manufacturing-wave.
- TechnologySmall-molecule API synthesis
Shares Generic oncology drug supply and shortage mitigation, Oral solid dose manufacturing (tablets and capsules), Generic sterile injectables (the 2023 platinum shortage) and the tag manufacturing-wave.
- TechnologyBCG manufacturing and the bladder cancer BCG shortage
Shares Generic oncology drug supply and shortage mitigation and the tag manufacturing-wave.
- CompanyCivica Rx
Shares Generic oncology drug supply and shortage mitigation, Generic sterile injectables (the 2023 platinum shortage).
- CompanyFresenius Kabi
Shares Generic oncology drug supply and shortage mitigation, Generic sterile injectables (the 2023 platinum shortage).
- CompanySandoz
Shares Oral solid dose manufacturing (tablets and capsules), Generic sterile injectables (the 2023 platinum shortage).
- CompanyIntas Pharmaceuticals (Accord Healthcare)
Shares Oral solid dose manufacturing (tablets and capsules), Generic sterile injectables (the 2023 platinum shortage).